T—DNA插入水稻群体中卷叶突变体R1—A2的遗传分析

在根癌农杆菌介导的T-DNA(携带有除草剂Basta抗性基因bar和Ds因子)转化中花11水稻群体中,获得了一个叶片发生明显内卷的突变体Rl-A。经过连续三代的分离鉴定,获得突变体的纯合株(Rl-A2),并与中花11号进行杂交,在调查的36个F1植株中,全部表现为卷叶,并对Basta除草剂都表现为抗性。在852个F2单株中,卷叶为645株,正常叶207株,卷叶和正常叶的比例为3：1,其中,卷叶株均对Basta表现抗性,正常叶株均对Basta表现敏感,表明卷叶性状和Basta抗性存在着共分离关系。用扩增DS因子的引物,对F2中45个卷叶抗性株进行PCR鉴定,都获得预期长度的Ds因子片段,进一步表明在这些卷叶的植株中都有T-DNA的插入;而30个正常叶敏感株都不能检测到DS的特征片段。在以卷叶突变(Rl-A2)为回交亲本的F1B1植株中,全部植株表现卷叶;在以中花11号为回交亲本的F1B1植株中,卷叶和正常叶植株的分离比为1：1。上述结果表明该卷叶突变是个显性突变,受一个基因所控制,且该基因的突变与T-DNA的插入有关。     

一份新型水稻极度分蘖突变体的遗传分析及分子标记定位

在三系杂交水稻保持系绵香1B（M1B）和一个雄性不育材料GMS-1的杂交后代中发现一株极度分蘖突变体（命名为ext．M1B）,其分蘖数为121。对ext-M1B与5个正常分蘖水稻品种杂交F1和F2代的遗传分析表明,ext-M1B的极度分蘖特性受一对隐性核基因控制。以2480B／ext-M1B的F2代作定位群体,用分子标记将ext-M1B的突变基因定位于水稻第6染色体短臂,该基因与微卫星标记RM197、RM584和RM225的遗传距离分别为3．8cM、5．1cM和5．2cM,认为ext-M1B突变基因是一个新的水稻极度分蘖基因,暂命名为ext-M1B（t）。     

普通小麦与东方旱麦草杂交世代的细胞遗传学研究

对普通小麦（TriticumaestivumL．）与东方旱麦草（Eremopyrumorientale（Ledeb）Jaub．etspach）属间杂种的回交和自交不同世代（BC2F1、BC3F1、BC2F2、BC3F2和BC2F3）进行了细胞遗传学研究。结果表明,BC2F1代（2n＝44）的植株回交产生的BC3F1代分离2n＝43植株的比例较高;为41．09％,2n＝44的植株类型的比例仅为4．11％;从自交后代BC2F2中分离2n=44植株类型的比例较高,为13．21％。回交二代（BC2F1）多数单株花粉母细胞（PMC）减数分裂过程中出现的单价体数较高,且回交结实率和自交结实率分别与该植株平均每PMC中出现的单价体数呈负相关,其相关系数分别为-0．6766和-0．7429。对BC2F3代部分种子进行的基因组原位杂交检测显示,2n＝44的不同植株所含有的外源染色体数目仍有不同。这些结果说明,由于外源染色体的存在,影响了小麦本身同源染色体的正常配对和分离,降低了小麦染色体的遗传稳定性。     

一个黄绿色的水稻细胞核突变体

用甲基磺酸乙酯(EMS)处理粳稻品种8126离体培养早期的花药,从所产生的一个花粉植株的H,株系中分离到一个黄绿色突变体。突变体植株叶片的叶绿素含量仅为正常叶片的1/3。突变性状稳定,在连续自交4代中,没有出现任何绿色植株;由突变体通过花药培养产生的植株除部分白化苗外均呈黄绿色。突变体与正常植株杂交,无论其为父本或母本,杂种F_1均为绿色植株;杂种F_2分离的绿色与黄绿色植株数比值符合3:1;由杂种F_1植株通过花药培养产生的小苗中绿苗与黄绿苗数的比值符合1:1。证明突变性状是由单一的隐性细胞核基因所控制。     

具野稻细胞质的胞质型雄性不育系的体细胞克隆变异II.体细胞克隆温敏核不育突变

在胞质型水稻雄性不育系IR66707A和IR69700A经离体培养而获得的136个体细胞克隆中,发现了温敏核不育突变5例。这类突变体在广州地区的自然气候下,早季至晚季前期表现为不育,晚季后期表现为可育。盛夏,在幼穗发育至花粉形成阶段对部分突变材料进行短日照处理,发现对短日照敏感的不育系农垦58S转换为可育,而供试的5例突变及另一对照培矮64S却与未经处理的材料一样仍表现为不育,表明它们的育性与日照长度的变化无关。在同一发育时期进行低温处理的结果显示,低温处理10d及10d以上者可发生育性转换,自交结实率在17.23%-42.19%之间,而未经处理的材料仍然表现不育,表明它们的育性转换与温度有关。以正常品种为父本与突变体杂交,F1全部为可育;F2可育与不育个体的分离比为3:1;以F1为父本与之测交,TF1代中可育与不育个体的分离比为1:1。遗传分析表明,这种温敏核不育突变为一对隐性核基因所控制。获得了由胞质型雄性不育变为胞核型雄性不育的突变体,这在体细胞克隆变异领域中是一种典型的突变。     

具野稻细胞质的胞质型雄性不育系的体细胞克隆变异Ⅱ.体细胞克隆温敏核不育突变

在胞质型水稻雄性不育系IR66707A和IR69700A经离体培养而获得的136个体细胞克隆中,发现了温敏核不育突变5例。这类突变体在广州地区的自然气候下,早季至晚季前期表现为不育,晚季后期表现为可育。盛夏,在幼穗发育至花粉形成阶段对部分突变材料进行短日照处理。发现对短日照敏感的不育系农垦58S转换为可育,而供试的5例突变及另一对照培矮64S却与未经处理的材料一样仍表现为不育,表明它们的育性与日照长度的变化无关,在同一发育时期进行低温处理的结果显示,低温处理10d及10d以上者可发生育性转换。自交结实率在17.23%-42.19%之间,而未经处理的材料仍然表现不育,表明它们的育性转换与温度有关,以正常品种为父本与突变体杂交,F1全部为可育;F2可育与不育个体的分离比为3：1,以F1为父本与之测交,TF1代中可育与不育具体的分离比为1：1。遗传分析表明,这种温敏核不育突变为一对隐性核基因所控制,获得了由胞质型雄性不育变为胞核型雄性不育的突变体。这在体细胞克隆变异领域中是一种典型的突变。     

一种桔小实蝇蛹白化突变体的遗传分析

在实验室饲养野生型桔小实蝇Bactrocera dorsalis(Hendel)过程中发现了一种蛹色为白色的桔小实蝇突变品系。根据孟德尔遗传规律,设计野生型与突变型杂交(正交和反交)、F_1代与突变型回交、F_1代自交以及F_2代突变型自交等实验,对蛹白化突变性状的遗传规律进行研究。结果显示野生型与突变型杂交F_1代蛹色全部为野生型;F_2代野生型和突变型的性状分离比为2.98∶1,回交实验野生型与突变型性状分离比为1.19∶1;而突变体自交后代(F_3代)全部为突变体。结果表明桔小实蝇蛹色白化突变品系的遗传规律符合孟德尔遗传规律,属于常染色体上单基因控制的隐性遗传性状。     

一个新的水稻D17/HTD1基因等位突变体的分子鉴定

株高和分蘖是水稻重要的农艺性状,直接影响到产量。本研究从粳稻品种日本晴的组培苗后代中分离出一个可稳定遗传的半矮化多分蘖突变体t489,相比野生型,突变体株高明显下降、分蘖能力明显增强。遗传分析表明该性状受1对隐性基因控制。进一步基因鉴定发现,突变体中编码植物激素独脚金内酯(SLs,Strigolactones)合成途径中的类胡萝卜素裂解双加氧酶7即D17/HTD1基因编码区第916 bp位置的碱基由G突变为T,导致蛋白翻译提前终止,仅编码305个氨基酸组成的蛋白,但此突变并未造成该基因转录水平的改变。基于此突变位点开发的dCAPS-D17标记与突变体和日本晴构建的BC1F2群体中的矮化多分蘖植株共分离,这表明G916T突变与表型相关,t489可能是一个新的D17/HTD1等位突变体。     

EMS诱变西瓜突变体库的构建及表型分析

采用1.0%诱变剂甲基磺酸乙酯(EMS)处理西瓜品系W1-17种子9h,然后对M1和M2代群体单株在叶、花、茎、育性、分支习性等方面进行表型变异观察,同时选取M2代典型变异株系,利用23对西瓜SSR引物进行分析鉴定,构建西瓜突变体库。结果表明:(1)EMS诱变使M1代幼苗形态呈现出叶畸形、叶褶皱、部分黄化、花畸形、雄花不散粉、卷须畸形、矮小、生长缓慢、不育等特异性状,获得由1 252个单株组成的西瓜突变体M1群体,群体总变异频率为18.33%。(2)M2代共筛选到205个突变植株,40种表型变异,表现在子叶性状(黄化、扭曲不对称、折叠等)、叶和茎性状(叶黄化、变小、裂刻变深,茎变细,节间变短,分支少等)、花性状(花变大,花色变浅,两性花,花瓣皱缩、部分退化、数目突变,柱头畸形,雄蕊不成熟等)和其他性状(生长缓慢、不育等)等方面,总的表型突变率达到了19.59%。(3)针对M2代10个典型变异植株,通过SSR引物分析发现有9份材料在DNA水平上有变异。本研究初步构建了含有120个M1代家系及1 051株M2代植株、40种表型变异的西瓜突变体库。     

一个水稻半矮化和花发育异常突变体的遗传分析和分子定位

从粳稻品种‘日本晴’经~(60)Co诱变的M_2代材料中发现一个半矮化并且花发育异常突变体sd-df3,其表现为植株半矮化,分蘖增加,半包茎穗,雄蕊发育不良,无花粉。遗传分析显示,该突变体表型受1对隐性核基因控制。以杂合型突变体为母本,与广亲和品种Dular杂交,构建F_2分离群体,将该基因定位在水稻第3号染色体,In/Del标记333591与333818之间的物理距离约为227kb的范围,目前该范围内没有矮化相关基因报道。     

Synthesis and biological evaluation of 1,3-oxathiolane 5-azapyrimidine, 6-azapyrimidine, and fluorosubstituted 3-deazapyrimidine nucleosides

(2R,5S)-5-Amino-2-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- 1,2,4-triazine-3(2H)-one (8) and (2R,5R)-5-amino-2-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2,4-tr iazine-3(2H)-one (9) have been synthesized via a multi-step procedure from 6-azauridine. (2R,5S)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,3, 5-triazine-2(1H)-one (11) and (2R,5R)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- 1,3,5-triazine-2(1H)-one (12), and the fluorosubstituted 3-deazanucleosides (19-24) have been synthesized by the transglycosylation of (2R,5S)-1-[2-[[(tert-butyldiphenylsilyl) oxy]methyl]-1,3-oxathiolan-5-yl] cytosine (2) with silylated 5-azacytosine and the corresponding silylated fluorosubstituted 3-deazacytosines, respectively, in the presence of trimethylsilyl trifluoromethanesulfonate as the catalyst in anhydrous dichloroethane, followed by deprotection of the blocking groups. These compounds were tested in vitro for cytotoxicity against L1210, B16F10, and CCRF-CEM tumor cell lines and for antiviral activity against HIV-1 and HBV.     

Synthesis and antibacterial activity of egonol derivatives

Synthesis of egonol derivatives, 5-(3'-chloropropyl)-7-methoxy-2-(3',4'-methylenedioxyphenyl)benzofuran 1, 5-(3'-bromopropyl)-7-methoxy-2-(3',4'-methylenedioxyphenyl)benzofuran 2, 3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propanal 3, 5-(3'-iodopropyl)-7-methoxy-2-(3',4'-methylenedioxyphenyl)benzofuran 4, 5-[3-(3'-bromopropyloxy) propyl]-7-methoxy-2-(3',4'-methylenedioxyphenyl)benzofuran 5, 3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propylmethanoate 6, 3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propyloleate 7, 5-[3'-hydroxypropyl]-6-bromo-7-methoxy-2-(3',4'-methylenedioxyphenyl)benzofuran 8, 4-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]butanenitrile 9, 3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propylbenzoate 10, 5-[3'-hydroxypropyl]-7-methoxy-3-nitro-2-(3',4'-methylenedioxyphenyl)benzofuran 11 and their antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Candida albicans and Escherichia coli are reported. The starting material egonol 5-[3'-(hydroxy)propyl]-7-methoxy-2-(3', 4'methylenedioxyphenyl)benzofuran was isolated from seeds of Styrax officinalis L. The structural elucidication of these compounds (1-11) was established using 1D ((1)H, (13)C), 2D NMR (HMBC, HMQC, COSY) and LCMS spectroscopic data. While egonol and some synthesised new compounds show similar antibacterial activity and MIC values against S. aureus, B. subtilis, C. albicans and E. coli, other new derivatives show different activity against S. aureus, B. subtilis, C. albicans and E. coli.     

Functional analysis of 2-5A-dependent RNase and 2-5a using 2',5'-oligoadenylate-cellulose

2-5A is an intracellular effector that has been implicated in interferon action, hormonal regulation, and cell growth control. 2-5A action is mediated through its activation of 2-5A-dependent RNase (RNase L, RNase F). Affinity resins [2-5A-cellulose and core (2-5A)-cellulose] were chemically synthesized for purification and immobilization of 2-5A-dependent RNase from mouse L cells and rabbit reticulocyte lysates. The breakdown of poly(U)-[3'-32P]Cp to acid-soluble fragments was demonstrated using the 2-5A-dependent RNase:2-5A -cellulose complex; this activity was enhanced by adding (free) 2-5A. In contrast, RNase activity was measured from the 2-5A-dependent RNase:core (2-5A)-cellulose complex only after the addition of free 2-5A. The rabbit reticulocyte 2-5A-dependent RNase is activated only by tetramer or higher oligomers of 2-5A; therefore there was breakdown of poly(U)-[3'-32P]Cp using core (2-5A)-cellulose-bound reticulocyte 2-5A-dependent RNase after addition of tetramer 2-5A but there was no poly(U) degradation in the presence of trimer 2-5A. The absence of significant general nuclease in the assays was demonstrated by the resistance to breakdown of poly(C)-[3'-32P]Cp (not susceptible to 2-5A-dependent RNase). Moreover, core (2-5A)-cellulose was used to develop a sensitive (subnanomolar) assay for the detection of authentic 2-5A. 2-5A, or the material to be tested, was added to mouse L-cell 2-5A-dependent RNase:core (2-5A)-cellulose complex in the presence of poly(U)-[3'-32P]Cp. The concentration of 2-5A in the sample could be measured from the amount of poly(U) degradation. Several closely related analogs of 2-5A were tested and found to be completely inactive. The technology described herein may be applied to the study of the regulation of 2-5A-dependent RNase, the detection of 2-5A from cells and tissues, and other aspects of the 2-5A system.     

Facile synthetic route to enantiopure unsymmetric cis-2,5-disubstituted pyrrolidines

The (+/-)-cis-5-arylcarbamoyl-2-ethoxycarbonylpyrrolidines 6a-g were firstly synthesized in 53-64% yields by using meso-diethyl-2,5-dibromoadipate 3 and (S)-(-)-1-phenylethylamine in three steps. The diastereomeric mixture (S;2S,5R)-(-)-7 and (S;2R,5S)-(+)-8 were prepared by the Grignard reaction and separated by a flash column chromatography in 29 and 52% yields. The absolute configurations of (+)-8 was confirmed by X-ray crystallographic analysis and the enantiopure pyrrolidines (2S,5R)-(-)-9/(2R,5S)-(+)-9 and (2S,5R)-(-)-10/(2R,5S)-(+)-10 were obtained in good yields.     

New bisabolane sesquiterpenes and coumarin from Leontopodium longifolium

From the roots of Leontopotium longifolium, three new bisabolane sesquiterpenes, rel-(1S,4R,5S,6R)-4,5-diacetoxy-6-[(R)-1,5-dimethylhexa-3,5-dienyl]-3-methylcyclohex-2-enyl (Z)-2-methylbut-2-enoate (1), rel-(1S,4R,5S,6R)-4,5-diacetoxy-6-[(R)-5-hydroxy-1,5-dimethylhex-3-enyl]-3-methylcyclohex-2-enyl (Z)-2-methylbut-2-enoate (2), rel-(1R,2S,4R,5S)-4-acetoxy-2-[(R)-5-hydroxy-1,5-dimethylhex-3-enyl]-5-methylcyclohexyl (Z)-2-methylbut-2-enoate (3), and a new coumarin, 2,3-dihydro-5-hydroxy-2-(1-methylethenyl)-7H-pyrano[2,3-g][1,4]benzodioxin-7-one (4) together with nine known compounds have been isolated. The structures of these compounds were established by spectroscopic methods. Compounds 1 and 2 exhibited moderate cytotoxic activities against human promyelocytic leukemia (HL-60) cells.     

Synthesis and biological activity of tubercidin analogues of ppp5'A2'p(5'A2'p)n5'A

A series of tubercidin (7-deazaadenosine) analogues of 2-5A of the general formula p5'(c7A)2'p[5'(c7A)-2'p]n5'(c7A) (n = 0-5) were prepared by lead ion catalyzed polymerization of the 5'-phosphoroimidazolidate of tubercidin. Through the corresponding imidazolidates, these oligonucleotide 5'-monophosphates were converted to the 5'-triphosphates. All reported structures were corroborated by enzyme digestion and 1H or 31P nuclear magnetic resonance. When evaluated for its ability to bind to the 2-5 A-dependent endonuclease of mouse L cells, the tubercidin analogue of trimeric 2-5A, namely, ppp5'(c7A)2'p5'(c7A)2'p5'(c7A), and the corresponding tetramer were bound as effectively as 2-5A itself; nonetheless, it and the corresponding tetramer, ppp5'-(c7A)2'p5'(c7A)2'p5'(c7A)2'p5'(c7A), failed to stimulate the 2-5A-dependent endonuclease as judged by its inability to inhibit translation in extracts of mouse L cells programmed with encephalomyocarditis virus RNA and to give rise to ribosomal RNA cleavage in the same cell system under conditions where 2-5A showed activity at 10(-9) M. The trimer, ppp5'(c7A)2'p5'(c7A)2'p5'(c7A), was an antagonist of 2-5A action in the L cell extract. In the lysed rabbit reticulocyte system, both the trimeric and tetrameric tubercidin 2-5A analogues were bound to the 2-5A-dependent endonuclease as well as 2-5A, but in this case, the tetramer triphosphate, ppp5'(c7A)2'p5'(c7A)2'p5'(c7A)2'p5'(c7A), was just as potent an inhibitor of translation as 2-5A tetramer triphosphate. Moreover, this inhibition was prevented by the established 2-5A antagonist p5'A2'p5'A2'p5'A.(ABSTRACT TRUNCATED AT 250 WORDS)     

Alpha-pyrones and a 2(5H)-furanone from Hyptis pectinata

Three pyrones and a 2(5H)-furanone, designated pectinolides D-G, have been isolated from the dichloromethane extract of Hyptis pectinata. The metabolites were characterized on the basis of 1D and 2D NMR spectroscopic techniques. The pyrones were identified as 6S-[3S,6S-(diacetoxy)-5R-hydroxy-1Z-heptenyl]-5S-hydroxy-5,6-dihydro-2H-pyran-2-one (1)- pectinolide D, 6S-[3S,5R,6S-(triacetoxy)-1Z-heptenyl]-5S-acetoxy-5,6-dihydro-2H-pyran-2-one (2)- pectinolide E and 6S-[3S,5R,6S-(triacetoxy)-1Z-heptenyl]-5S-acetoxy-4R-methoxy-3,4,5,6-tetrahydro-4H pyran-2-one (3)- pectinolide F. The furanone was identified as [2'Z,5(1')Z] 5-(4'S,6'R,7'S-triacetoxy-2-octenylidene)-2(5H)-furanone (4)-pectinolide G.     

Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro

The following structurally diverse 5-substituted-2'-deoxyuridine nucleosides displayed potent in vitro antileishmanial activity: 5-formyl, 5-(2,2,-dicyanovinyl)-, 5-(2-cyano-2-ethoxycarbonylvinyl), 5-(2-cyano-2-methoxycarbonylvinyl)-, 5-(2-amino-3-cyano-5-oxo-5,6,7,8-tetrahydro-4H-chromen-4-yl)- and related congeners, and the 5-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-4H-pyrazol-4-ylidene) group.     

Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphan

Enantiomeric analogues of 5-(3-hydroxyphenyl)morphan ligands were synthesized and evaluated because of our unexpected finding that opioid antagonists can be obtained in the 5-phenylmorphan series of opioids without sterically hindering the rotation of the phenolic ring. We determined the opioid receptor binding affinity of these new analogues, as well as the efficacy of the more interesting ligands. One of the new compounds [(1R,5S)-(-)-3-[2-(3'-phenylpropyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol, 15] was found to have half of the efficacy of naloxone, a potent opioid antagonist, in the [(35)S]GTPgammaS assay, and two others (1R,5S)-(-)-3-[2-(4'-phenylbutyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol, 17, and (1R,5S,1'S)-(+)-3-[2-(1'-methyl-2'-phenylethyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol, 26, acted as moderately potent opioid antagonists. X-ray crystallographic structure data were obtained on three compounds. Two of them had three chiral centers; 25 [(1R,5S,1'R)-(-)-3-[2-(1'-methyl-2'-phenylethyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol] was determined to have the 1R,5S,1'R configuration, and 26 the 1R,5S,1'S configuration. Since (1S,5R)-(+)-2-bromo-5-[2-(2'-phenylethyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol (32) was a position isomer of (1S,5R)-(+)-4-bromo-3-[2-(2'-phenylethyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol (30), and both showed the same 1H NMR spectrum, the structure of 32 was unequivocally determined by X-ray structure analysis.     

Biosynthetic studies on the alpha-glucosidase inhibitor acarbose: the chemical synthesis of isotopically labeled 2-epi-5-epi-valiolone analogs

2-epi-5-epi-valiolone is a cyclization product of the C(7) sugar phosphate, sedoheptulose 7-phosphate, involved in the biosynthesis of the aminocyclitol moieties of acarbose, validamycin, and pyralomicin. As part of our investigation into the pathway from 2-epi-5-epi-valiolone to the valienamine moiety of acarbose, we prepared 1-epi-5-epi-(6-(2)H(2))valiolol [(6-(2)H(2))-6], 5-epi-(6-(2)H(2))valiolol [(6-(2)H(2))-17], 1-epi-2-epi-5-epi-(6-(2)H(2))valiolol [(6-(2)H(2))-12] and 2-epi-5-epi-(6-(2)H(2))valiolamine [(6-(2)H(2))-11]. Compounds (6-(2)H(2))-6 and (6-(2)H(2))-17 were synthesized from 2,3,4,6-tetra-O-benzyl-D-glucopyranose in 10 and seven steps, respectively, whereas (6-(2)H(2))-12 and (6-(2)H(2))-11 were synthesized from 2,3,4,6-tetra-O-benzyl-D-mannopyranose in eight and 10 steps, respectively.